VITROS SARS-CoV-2 Antigen Reagent Kit for Immunodiagnostic Detection of the SARS-CoV-2 Nucleocapsid Antigen

VITROS SARS-CoV-2 Antigen Reagent Kit for Immunodiagnostic Detection of the SARS-CoV-2 Nucleocapsid Antigen

The reagent kit is designed for the immunodiagnostic determination of the SARS-CoV-2 nucleocapsid antigen in nasopharyngeal and oropharyngeal swab samples using the enhanced chemiluminescence method on VITROS series analyzers, lots 0061 and 0062.

Kit Contents:

• VITROS SARS-CoV-2 Antigen Reagent Pack – for immunodiagnostic detection of the SARS-CoV-2 nucleocapsid antigen in nasopharyngeal and oropharyngeal swabs using enhanced chemiluminescence on VITROS analyzers, lots 0061 and 0062 – 1 pack.
• VITROS SARS-CoV-2 Antigen Extraction Buffer – for extraction of the SARS-CoV-2 virus from nasopharyngeal and oropharyngeal swabs, lot 0012 – up to 1 package containing 4 vials of 28 ml each (if required).
• Operating documentation for the medical device – 1 copy.

If your organization wants to sell medical equipment, medical products or medical consumables in Russia, for example, VITROS SARS-CoV-2 Antigen Reagent Kit for Immunodiagnostic Detection of the SARS-CoV-2 Nucleocapsid Antigen, then our information portal MEDCOMMERCE can help you with this. To do this, simply fill out the feedback form by clicking on the link FEEDBACK FORM.

The products posted on our website are approved for use in Russia by the state regulator Roszdravnadzor (Federal Service for Surveillance in Healthcare). The information is for informational purposes only.